Turkish Ministry of Health, Ankara Numune Training and Research Hospital, Department of Endocrinology and Metabolism, Talatpasa Bulvari, Samanpazari, 06100-Ankara, Turkey.
J Endocrinol Invest. 2013 Oct;36(9):681-5. doi: 10.3275/8923. Epub 2013 Apr 2.
Obstructive sleep apnea syndrome (OSAS) is a widespread disorder characterized by recurrent, partial or complete episodes of apnea due to upper airway tract obstruction during sleeping period. Deficiency of vitamin D has roles in development of many diseases. Association between presence and severity of OSAS and vitamin D has recently gained research interest.
The aim of our study was to investigate the association between serum 25-hydroxy [25 (OH)] vitamin D levels and severity of disease in patients with OSAS.
One hundred and fifty OSAS patients (50 patients with mild, 50 with moderate, 50 with severe OSAS) who were diagnosed by polysomnography (PSG) and 32 non-OSAS controls who were referred to the Health Ministry Ankara Numune Training and Research Hospital, Endocrinology and Metabolism Department, from January 2010 to May 2011 were included in the study. Serum 25(OH)D, PTH, calcium and phosphorus levels were evaluated in all the patients who were recruited to the study.
There was no statistically significant difference in serum 25(OH)D levels between OSAS and controls (p>0.05). However, in subgroup analysis of OSAS, we found that the patients with severe OSAS had significantly lower levels of 25(OH)D as compared with other groups (p=0.003). Also, the number of patients with serum 25(OH)D deficiency (<10 μg/dl) were higher in OSAS group than in controls (p<0.05).
We found that when the severity of OSAS increases, 25(OH)D deficiency becomes more pronounced.
阻塞性睡眠呼吸暂停综合征(OSAS)是一种广泛存在的疾病,其特征是在睡眠期间由于上呼吸道阻塞而反复出现部分或完全的呼吸暂停。维生素 D 缺乏在许多疾病的发展中起作用。OSAS 的存在和严重程度与维生素 D 之间的关联最近引起了研究兴趣。
我们的研究旨在探讨血清 25-羟维生素 D [25(OH)]水平与 OSAS 患者疾病严重程度之间的关系。
2010 年 1 月至 2011 年 5 月,我们共纳入了 150 名经多导睡眠图(PSG)诊断为 OSAS 的患者(轻度 50 例、中度 50 例、重度 50 例)和 32 名非 OSAS 对照者。所有患者均进行了血清 25(OH)D、甲状旁腺激素(PTH)、钙和磷水平的评估。
OSAS 患者和对照组之间的血清 25(OH)D 水平无统计学差异(p>0.05)。然而,在 OSAS 的亚组分析中,我们发现重度 OSAS 患者的 25(OH)D 水平明显低于其他组(p=0.003)。此外,OSAS 组血清 25(OH)D 缺乏症(<10μg/dl)患者的数量也高于对照组(p<0.05)。
随着 OSAS 严重程度的增加,25(OH)D 缺乏症变得更加明显。